{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T00:55:29Z","timestamp":1788310529491,"version":"build-2803163510"},"reference-count":38,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2011,2,1]],"date-time":"2011-02-01T00:00:00Z","timestamp":1296518400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,2,1]],"date-time":"2011-02-01T00:00:00Z","timestamp":1296518400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2013,8,22]],"date-time":"2013-08-22T00:00:00Z","timestamp":1377129600000},"content-version":"vor","delay-in-days":933,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100004374","name":"Medtronic","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004374","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005564","name":"Gilead Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005564","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006279","name":"St. Jude Medical","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006279","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: Cardiovascular Interventions"],"published-print":{"date-parts":[[2011,2]]},"DOI":"10.1016\/j.jcin.2010.10.003","type":"journal-article","created":{"date-parts":[[2011,2,23]],"date-time":"2011-02-23T05:03:39Z","timestamp":1298437419000},"page":"176-182","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":83,"title":["Continued Benefit From Paclitaxel-Eluting Compared With Bare-Metal Stent Implantation in Saphenous Vein Graft Lesions During Long-Term Follow-Up of the SOS (Stenting of Saphenous Vein Grafts) Trial"],"prefix":"10.1016","volume":"4","author":[{"given":"Emmanouil S.","family":"Brilakis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Lichtenwalter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdul-rahman R.","family":"Abdel-karim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James A.","family":"de Lemos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Owen","family":"Obel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tayo","family":"Addo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Roesle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donald","family":"Haagen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bavana V.","family":"Rangan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bilal","family":"Saeed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph K.","family":"Bissett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajesh","family":"Sachdeva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vassilios V.","family":"Voudris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Panagiotis","family":"Karyofillis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Biswajit","family":"Kar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Rossen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Panayotis","family":"Fasseas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Berger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Subhash","family":"Banerjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcin.2010.10.003_bib1","doi-asserted-by":"crossref","first-page":"722","DOI":"10.4244\/EIJV5I6A119","article-title":"Drug-eluting stents in saphenous vein graft interventions: a systematic review","volume":"5","author":"Brilakis","year":"2010","journal-title":"EuroIntervention"},{"key":"10.1016\/j.jcin.2010.10.003_bib2","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1016\/j.jacc.2006.09.021","article-title":"Randomized double-blind comparison of sirolimus-eluting stent versus bare-metal stent implantation in diseased saphenous vein grafts: six-month angiographic, intravascular ultrasound, and clinical follow-up of the RRISC trial","volume":"48","author":"Vermeersch","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jcin.2010.10.003_bib3","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.jacc.2007.05.010","article-title":"Increased late mortality after sirolimus-eluting stents versus bare-metal stents in diseased saphenous vein grafts: results from the randomized DELAYED RRISC trial","volume":"50","author":"Vermeersch","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jcin.2010.10.003_bib4","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/j.jacc.2008.11.029","article-title":"A randomized controlled trial of a paclitaxel-eluting stent versus a similar bare-metal stent in saphenous vein graft lesions the SOS (Stenting of Saphenous Vein Grafts) trial","volume":"53","author":"Brilakis","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jcin.2010.10.003_bib5","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/j.jcin.2009.06.014","article-title":"Clinical presentation and angiographic characteristics of saphenous vein graft failure after stenting: insights from the SOS (Stenting of Saphenous Vein Grafts) trial","volume":"2","author":"Lichtenwalter","year":"2009","journal-title":"J Am Coll Cardiol Intv"},{"key":"10.1016\/j.jcin.2010.10.003_bib6","first-page":"263","article-title":"Contemporary use of embolic protection devices in saphenous vein graft interventions: insights from the Stenting of Saphenous Vein Grafts trial","volume":"76","author":"Badhey","year":"2010","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.jcin.2010.10.003_bib7","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1161\/CIRCULATIONAHA.106.685313","article-title":"Clinical end points in coronary stent trials: a case for standardized definitions","volume":"115","author":"Cutlip","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.jcin.2010.10.003_bib8","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1016\/j.amjcard.2009.12.006","article-title":"Comparison by meta-analysis of drug-eluting stents and bare metal stents for saphenous vein graft intervention","volume":"105","author":"Lee","year":"2010","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jcin.2010.10.003_bib9","doi-asserted-by":"crossref","first-page":"e11040","DOI":"10.1371\/journal.pone.0011040","article-title":"Drug-eluting versus bare-metal stent for treatment of saphenous vein grafts: a meta-analysis","volume":"5","author":"Meier","year":"2010","journal-title":"PloS One"},{"key":"10.1016\/j.jcin.2010.10.003_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.ahj.2009.11.021","article-title":"Effectiveness and safety of drug-eluting stents in vein grafts: a meta-analysis","volume":"159","author":"Joyal","year":"2010","journal-title":"Am Heart J"},{"key":"10.1016\/j.jcin.2010.10.003_bib11","doi-asserted-by":"crossref","first-page":"149","DOI":"10.4244\/EIJV6I1A22","article-title":"Safety and efficacy of drug-eluting stents versus bare-metal stents in saphenous vein grafts lesions: a meta-analysis","volume":"6","author":"Sanchez-Recalde","year":"2010","journal-title":"EuroIntervention"},{"key":"10.1016\/j.jcin.2010.10.003_bib12","doi-asserted-by":"crossref","first-page":"527","DOI":"10.4244\/EIJ30V6I4A87","article-title":"Drug eluting stent versus bare metal stent in the treatment of saphenous vein graft disease","volume":"6","author":"Testa","year":"2010","journal-title":"EuroIntervention"},{"key":"10.1016\/j.jcin.2010.10.003_bib13","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1161\/CIRCULATIONAHA.109.874057","volume":"120","author":"Rodes-Cabau","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.jcin.2010.10.003_bib14","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1111\/j.1540-8183.2007.00301.x","article-title":"Long-term clinical benefit of sirolimus-eluting stents compared to bare metal stents in the treatment of saphenous vein graft disease","volume":"20","author":"Minutello","year":"2007","journal-title":"J Interv Cardiol"},{"key":"10.1016\/j.jcin.2010.10.003_bib15","first-page":"58","article-title":"Percutaneous intervention on the saphenous vein bypass grafts: long-term outcomes","volume":"71","author":"Bansal","year":"2008","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.jcin.2010.10.003_bib16","first-page":"13","article-title":"Lack of clinical long-term benefit with the use of a drug eluting stent compared to use of a bare metal stent in saphenous vein grafts","volume":"72","author":"Gioia","year":"2008","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.jcin.2010.10.003_bib17","first-page":"886","article-title":"Long-term clinical outcomes of real-world experience using sirolimus-eluting stents in saphenous vein graft disease","volume":"71","author":"Ramana","year":"2008","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.jcin.2010.10.003_bib18","first-page":"7","article-title":"Late outcomes of drug-eluting versus bare metal stents in saphenous vein grafts: propensity score analysis","volume":"72","author":"Applegate","year":"2008","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.jcin.2010.10.003_bib19","doi-asserted-by":"crossref","first-page":"108","DOI":"10.4244\/EIJV4I1A18","article-title":"Beneficial 2-years results of drug-eluting stents in saphenous vein graft lesions","volume":"4","author":"Assali","year":"2008","journal-title":"EuroIntervention"},{"key":"10.1016\/j.jcin.2010.10.003_bib20","doi-asserted-by":"crossref","first-page":"311","DOI":"10.4244\/EIJV4I3A57","article-title":"Four-year safety and efficacy of the unrestricted use of sirolimus- and paclitaxel-eluting stents in coronary artery bypass grafts","volume":"4","author":"van Twisk","year":"2008","journal-title":"EuroIntervention"},{"key":"10.1016\/j.jcin.2010.10.003_bib21","first-page":"6971","article-title":"Late lumen loss of drug eluting stents versus bare mental stents for saphenous vein graft intervention","volume":"12","author":"Guo","year":"2008","journal-title":"J Clin Rehabilitative Tissues Eng Res"},{"key":"10.1016\/j.jcin.2010.10.003_bib22","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0300-8932(09)70019-3","article-title":"Comparison of drug-eluting and bare metal stents in saphenous vein grafts","volume":"62","author":"Lozano","year":"2009","journal-title":"Rev Esp Cardiol"},{"key":"10.1016\/j.jcin.2010.10.003_bib23","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.ahj.2009.08.003","article-title":"Drug-eluting versus bare-metal stents for treating saphenous vein grafts","volume":"158","author":"Shishehbor","year":"2009","journal-title":"Am Heart J"},{"key":"10.1016\/j.jcin.2010.10.003_bib24","first-page":"93","article-title":"Long-term outcomes of drug-eluting stents versus bare-metal stents in saphenous vein graft disease: results from the Prairie \u201cReal World\u201d Stent Registry","volume":"75","author":"Goswami","year":"2009","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.jcin.2010.10.003_bib25","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1016\/j.jcin.2009.08.020","article-title":"Outcomes with drug-eluting versus bare-metal stents in saphenous vein graft intervention: results from the STENT (Strategic Transcatheter Evaluation of New Therapies) Group","volume":"2","author":"Brodie","year":"2009","journal-title":"J Am Coll Cardiol Intv"},{"key":"10.1016\/j.jcin.2010.10.003_bib26","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1161\/CIRCINTERVENTIONS.109.929042","article-title":"Comparison of the long-term safety and efficacy of drug-eluting and bare-metal stent implantation in saphenous vein grafts","volume":"3","author":"Latib","year":"2010","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.jcin.2010.10.003_bib27","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1016\/j.amjcard.2010.05.025","article-title":"Comparison of drug-eluting and bare metal stents for saphenous vein graft lesions (from the National Heart, Lung, and Blood Institute Dynamic Registry)","volume":"106","author":"Baldwin","year":"2010","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jcin.2010.10.003_bib28","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1159\/000137699","article-title":"Drug-eluting stents compared with bare metal stents improve late outcome after saphenous vein graft but not after large native vessel interventions","volume":"112","author":"Jeger","year":"2008","journal-title":"Cardiology"},{"key":"10.1016\/j.jcin.2010.10.003_bib29","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.jacc.2007.05.011","article-title":"\u201cCrying fire in a theater\u201d or a \u201cconfirmatory sighting?\u201d","volume":"50","author":"Ellis","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jcin.2010.10.003_bib30","first-page":"404","article-title":"Utility of sirolimus-eluting Cypher stents to reduce 12-month target vessel revascularization in saphenous vein graft stenoses: results of a multicenter 350-patient case-control study","volume":"19","author":"Ellis","year":"2007","journal-title":"J Invasive Cardiol"},{"key":"10.1016\/j.jcin.2010.10.003_bib31","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/j.jcin.2010.04.012","article-title":"Outcomes after implantation of the Taxus paclitaxel-eluting stent in saphenous vein graft lesions: results from the ARRIVE (TAXUS Peri-Approval Registry: A Multicenter Safety Surveillance) program","volume":"3","author":"Brilakis","year":"2010","journal-title":"J Am Coll Cardiol Intv"},{"key":"10.1016\/j.jcin.2010.10.003_bib32","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.amjcard.2010.03.030","article-title":"Comparison of sirolimus-eluting stents with paclitaxel-eluting stents in saphenous vein graft intervention (from a Multicenter Southern California Registry)","volume":"106","author":"Lee","year":"2010","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jcin.2010.10.003_bib33","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/j.1540-8183.2006.00118.x","article-title":"Efficacy of sirolimus-eluting stents as compared to paclitaxel-eluting stents for saphenous vein graft intervention","volume":"19","author":"Chu","year":"2006","journal-title":"J Interv Cardiol"},{"key":"10.1016\/j.jcin.2010.10.003_bib34","first-page":"431","article-title":"Treatment of saphenous vein graft lesions with paclitaxel- and sirolimus-eluting stents: comparison of short- and long-term clinical outcomes","volume":"8","author":"Gormez","year":"2008","journal-title":"Anadolu Kardiyol Derg"},{"key":"10.1016\/j.jcin.2010.10.003_bib35","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1016\/j.amjcard.2010.08.008","article-title":"Could paclitaxel-eluting stents be superior to sirolimus-eluting stents for the treatment of saphenous vein graft lesions?","volume":"106","author":"Brilakis","year":"2010","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jcin.2010.10.003_bib36","first-page":"I396","article-title":"Impact of internal mammary artery conduit on long-term outcomes after percutaneous intervention of saphenous vein graft","volume":"114","author":"Mehta","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.jcin.2010.10.003_bib37","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.carrev.2008.12.002","article-title":"Comparison of percutaneous coronary intervention in native coronary arteries vs. bypass grafts in patients with prior coronary artery bypass graft surgery","volume":"10","author":"Varghese","year":"2009","journal-title":"Cardiovasc Revasc Med"},{"key":"10.1016\/j.jcin.2010.10.003_bib38","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1016\/j.jcin.2010.07.009","article-title":"Frequency and predictors of drug-eluting stent use in saphenous vein bypass graft percutaneous coronary interventions: a report from the American College of Cardiology National Cardiovascular Data CathPCI registry","volume":"3","author":"Brilakis","year":"2010","journal-title":"J Am Coll Cardiol Intv"}],"container-title":["JACC: Cardiovascular Interventions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936879810007120?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936879810007120?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T17:56:41Z","timestamp":1761847001000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1936879810007120"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,2]]},"references-count":38,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,2]]}},"alternative-id":["S1936879810007120"],"URL":"https:\/\/doi.org\/10.1016\/j.jcin.2010.10.003","relation":{},"ISSN":["1936-8798"],"issn-type":[{"value":"1936-8798","type":"print"}],"subject":[],"published":{"date-parts":[[2011,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Continued Benefit From Paclitaxel-Eluting Compared With Bare-Metal Stent Implantation in Saphenous Vein Graft Lesions During Long-Term Follow-Up of the SOS (Stenting of Saphenous Vein Grafts) Trial","name":"articletitle","label":"Article Title"},{"value":"JACC: Cardiovascular Interventions","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcin.2010.10.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}